Philip S. Wells

30.7k total citations · 10 hit papers
299 papers, 19.7k citations indexed

About

Philip S. Wells is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Philip S. Wells has authored 299 papers receiving a total of 19.7k indexed citations (citations by other indexed papers that have themselves been cited), including 245 papers in Internal Medicine, 160 papers in Cardiology and Cardiovascular Medicine and 62 papers in Surgery. Recurrent topics in Philip S. Wells's work include Venous Thromboembolism Diagnosis and Management (245 papers), Atrial Fibrillation Management and Outcomes (120 papers) and Central Venous Catheters and Hemodialysis (54 papers). Philip S. Wells is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (245 papers), Atrial Fibrillation Management and Outcomes (120 papers) and Central Venous Catheters and Hemodialysis (54 papers). Philip S. Wells collaborates with scholars based in Canada, United States and France. Philip S. Wells's co-authors include Marc Rodger, Clive Kearon, Susan R. Kahn, Henri Bounameaux, Mark Crowther, Paolo Prandoni, David R. Anderson, Anthony J. Comerota, Michael Gould and T. J. Neep and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Philip S. Wells

284 papers receiving 19.0k citations

Hit Papers

Antithrombotic Therapy fo... 2001 2026 2009 2017 2012 2003 2001 2005 2017 1000 2.0k 3.0k 4.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Antithrombotic Therapy for VTE Disease
    2012 4.5k citations Philip S. Wells, Mark Crowther et al. CHEST Journal profile →
  2. Evaluation of D-Dimer in the Diagnosis of Suspected Deep-Vein Thrombosis
    2003 990 citations Philip S. Wells, David R. Anderson et al. profile →
  3. Excluding Pulmonary Embolism at the Bedside without Diagnostic Imaging: Management of Patients with Suspected Pulmonary Embolism Presenting to the Emergency Department by Using a Simple Clinical Model and d-dimer
    2001 934 citations Philip S. Wells, David R. Anderson et al. profile →
  4. Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis
    2005 581 citations Philip S. Wells et al. Blood profile →
  5. Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism
    2017 492 citations Peter Verhamme, Philip S. Wells et al. profile →
  6. Antithrombotic Therapy for VTE Disease
    2021 487 citations Scott M. Stevens, Scott C. Woller et al. CHEST Journal profile →
  7. Diagnosis of DVT
    2012 455 citations Scott M. Stevens, Philip S. Wells et al. CHEST Journal profile →
  8. Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies
    2013 427 citations Philip S. Wells et al. profile →
  9. Executive Summary
    2021 228 citations Scott M. Stevens, Scott C. Woller et al. CHEST Journal profile →
  10. Antithrombotic Therapy for VTE Disease
    2024 37 citations Scott M. Stevens, Scott C. Woller et al. CHEST Journal profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Philip S. Wells 14.9k 10.4k 5.6k 3.2k 3.2k 299 19.7k
Henri Bounameaux 17.4k 1.2× 11.4k 1.1× 5.6k 1.0× 3.2k 1.0× 3.3k 1.0× 222 20.9k
Gary E. Raskob 13.3k 0.9× 11.1k 1.1× 4.8k 0.9× 3.2k 1.0× 2.3k 0.7× 170 19.6k
Russell D. Hull 13.3k 0.9× 9.0k 0.9× 5.5k 1.0× 2.4k 0.7× 2.3k 0.7× 242 16.4k
Walter Ageno 13.7k 0.9× 11.4k 1.1× 4.0k 0.7× 3.6k 1.1× 1.9k 0.6× 557 20.5k
Susan R. Kahn 20.3k 1.4× 11.5k 1.1× 10.0k 1.8× 4.2k 1.3× 5.4k 1.7× 330 25.8k
Menno V. Huisman 20.0k 1.3× 15.5k 1.5× 5.8k 1.0× 3.2k 1.0× 3.5k 1.1× 469 29.6k
Giancarlo Agnelli 11.6k 0.8× 9.3k 0.9× 3.5k 0.6× 1.9k 0.6× 2.4k 0.8× 335 16.4k
Marc Rodger 9.9k 0.7× 6.6k 0.6× 3.3k 0.6× 3.9k 1.2× 1.7k 0.5× 271 14.6k
John A. Heit 23.7k 1.6× 15.2k 1.5× 9.3k 1.7× 6.5k 2.0× 4.3k 1.4× 220 30.9k
Grégoire Le Gal 10.2k 0.7× 6.3k 0.6× 3.2k 0.6× 2.1k 0.6× 2.0k 0.6× 409 13.7k

Countries citing papers authored by Philip S. Wells

Since Specialization
Citations

This map shows the geographic impact of Philip S. Wells's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip S. Wells with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip S. Wells more than expected).

Fields of papers citing papers by Philip S. Wells

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip S. Wells. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip S. Wells. The network helps show where Philip S. Wells may publish in the future.

Co-authorship network of co-authors of Philip S. Wells

This figure shows the co-authorship network connecting the top 25 collaborators of Philip S. Wells. A scholar is included among the top collaborators of Philip S. Wells based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip S. Wells. Philip S. Wells is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Righini, Marc, Sam Schulman, Venkatesh Thiruganasambandamoorthy, et al.. (2025). Performance of clinical decision rules in patients presenting with suspected recurrent venous thromboembolism: a multicenter prospective cohort study. Journal of Thrombosis and Haemostasis. 23(10). 3239–3250.
3.
Perkins, Theodore J., et al.. (2024). A deep-learning approach to predict bleeding risk over time in patients on extended anticoagulation therapy. Journal of Thrombosis and Haemostasis. 22(7). 1997–2008. 3 indexed citations
4.
Stevens, Scott M., Scott C. Woller, Lisa Baumann Kreuziger, et al.. (2024). Antithrombotic Therapy for VTE Disease. CHEST Journal. 166(2). 388–404. 37 indexed citations breakdown →
5.
6.
Caiano, Lucia, Michael J. Kovacs, Alejandro Lazo‐Langner, et al.. (2023). The risk of major bleeding in patients with factor V Leiden or prothrombin G20210A gene mutation while on extended anticoagulant treatment for venous thromboembolism. Journal of Thrombosis and Haemostasis. 21(3). 553–558. 3 indexed citations
7.
Wang, Tzu‐Fei, Marc Carrier, Ranjeeta Mallick, et al.. (2023). Thrombophilia gene mutations predict venous thromboembolism in ambulatory cancer patients receiving chemotherapy. Journal of Thrombosis and Haemostasis. 21(11). 3184–3192. 4 indexed citations
8.
Sanfilippo, Kristen M., Tzu‐Fei Wang, Marc Carrier, et al.. (2022). Standardization of risk prediction model reporting in cancer‐associated thrombosis: Communication from the ISTH SSC subcommittee on hemostasis and malignancy. Journal of Thrombosis and Haemostasis. 20(8). 1920–1927. 4 indexed citations
9.
Skeith, Leslie, Marc Rodger, Elham Sabri, et al.. (2021). Long‐term risk of recurrent venous thromboembolism after a first contraceptive‐related event: Data from REVERSE cohort study. Journal of Thrombosis and Haemostasis. 19(6). 1526–1532. 6 indexed citations
10.
Peacock, W. Frank, Craig I Coleman, Philip S. Wells, et al.. (2019). Clinical and Economic Outcomes in Low-risk Pulmonary Embolism Patients Treated with Rivaroxaban versus Standard of Care. Journal of health economics and outcomes research. 6(3). 160–173. 1 indexed citations
11.
Carrier, Marc, Judy Kovacs, Marc Rodger, et al.. (2017). Association between remote major venous thromboembolism risk factors and the risk of recurrence after a first unprovoked episode. Journal of Thrombosis and Haemostasis. 15(10). 1977–1980. 2 indexed citations
12.
Bikdeli, Behnood, Babak Sharif-Kashani, Reina Valle, et al.. (2017). Abstract 13912: Impact of Thrombus Sidedness on Presentation and Outcomes of Patients With Proximal Lower Extremity Deep Vein Thrombosis: An Analysis From RIETE Registry. Circulation. 1 indexed citations
13.
Lazo‐Langner, Alejandro, Susan R. Kahn, Philip S. Wells, et al.. (2016). Post-Thrombotic Syndrome and Functional Disability in Patients with Upper Extremity Deep Vein Thrombosis: A Prospective Cohort Study. Blood. 128(22). 417–417. 3 indexed citations
14.
Wang, Li, Onur Başer, Philip S. Wells, et al.. (2016). Abstract 13112: Benefit of Early Discharge Among Patients With Low-risk Pulmonary Embolism: Focus on Net Clinical Impact. Circulation. 134(suppl_1). 1 indexed citations
15.
16.
Rodger, Marc, John Kingdom, Susan R. Kahn, et al.. (2013). The Thrombophilia in Pregnancy Prophylaxis Study (TIPPS): a multi-national randomized trial of dalteparin vs. no dalteparin to prevent pregnancy complications in pregnant thrombophilic women. Adelaide Research & Scholarship (AR&S) (University of Adelaide). 2 indexed citations
17.
Gong, Inna Y., Ute I. Schwarz, Natalie Crown, et al.. (2011). Clinical and Genetic Determinants of Warfarin Pharmacokinetics and Pharmacodynamics during Treatment Initiation. PLoS ONE. 6(11). e27808–e27808. 62 indexed citations
18.
Heshka, Jodi, et al.. (2008). A systematic review of perceived risks, psychological and behavioral impacts of genetic testing. Genetics in Medicine. 10(1). 19–32. 253 indexed citations
19.
Wells, Philip S., et al.. (2003). Use of Oral Vitamin K1 by Patients Taking Warfarin Sodium: Experience in an Ambulatory Care Clinic. The Canadian Journal of Hospital Pharmacy. 56(2).
20.
Rodger, Marc, Marc Carrier, Gwynne Jones, et al.. (2000). Diagnostic Value of Arterial Blood Gas Measurement in Suspected Pulmonary Embolism. American Journal of Respiratory and Critical Care Medicine. 162(6). 2105–2108. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Henri Bounameaux Breakdown of academic impact, for papers by Gary E. Raskob Breakdown of academic impact, for papers by Russell D. Hull Breakdown of academic impact, for papers by Walter Ageno Breakdown of academic impact, for papers by Susan R. Kahn Breakdown of academic impact, for papers by Menno V. Huisman Breakdown of academic impact, for papers by Giancarlo Agnelli Breakdown of academic impact, for papers by Marc Rodger Breakdown of academic impact, for papers by John A. Heit Breakdown of academic impact, for papers by Grégoire Le Gal
Rankless by CCL
2026